Navigation Links
AAIPharma Announces Promotion Of Dean Shirazi To EVP Of Analytical Laboratories
Date:12/12/2012

WILMINGTON, N.C., Dec. 12, 2012 /PRNewswire/ -- AAIPharma Services Corp. ("AAIPharma"), a leading provider of pharmaceutical product development services, announced today that it has promoted Dean Shirazi, Ph.D. to executive vice president of analytical laboratories.

(Logo: http://photos.prnewswire.com/prnh/20121207/MM26042LOGO)  

During his 20 year career at AAIPharma, Dr. Shirazi has helped AAIPharma excel in analytical chemistry and product development, most recently as vice president of analytical development.  With over 50 publications in scientific journals and a reference book in chromatography ("Fundamentals of Preparative and Nonlinear Chromatography, Second Edition"), Dr. Shirazi is a recognized expert in multiple types of liquid chromatography and gas chromatography.  Throughout his tenure, he has hired and trained a significant portion of laboratory personnel at AAIPharma, helping AAIPharma establish its leadership position in analytical chemistry and drug development.  In his new role, Dr. Shirazi will have responsibilities over the Wilmington and Durham analytical laboratories.   

"At AAIPharma, it has been an honor to work with thousands of clients throughout the industry," said Dr. Shirazi.  "My team and I look forward to continuing to help clients with their unique analytical challenges."

"The tenured analytical teams have long been the cornerstone of AAIPharma," said Patrick Walsh, Chief Executive Officer.  "As we continue to add new analytical capabilities in our new Wilmington Technology Center, Dr. Shirazi's analytical and regulatory expertise continues to be instrumental in coordinating our growth strategy."

Dr. Shirazi received his doctorate in analytical chemistry from Georgetown University. He conducted post-doctoral research at the University of Tennessee as a research associate, and his areas of interest are high performance liquid chromatography (HPLC), gas chromatography (GC), preparative chromatography, chiral separation and optimization of experimental conditions in chromatography.

About AAIPharma Services Corp. 

AAIPharma Services Corp. is a leading provider of contract services that support all phases of drug development. The company's wide array of capabilities includes analytical chemistry, formulation development, material testing services, microbiology, clinical and commercial contract manufacturing, pharmaceutical packaging and stability services. Serving more than 600 clients around the globe and headquartered in Wilmington, N.C., AAIPharma is a portfolio company of Water Street Healthcare Partners, a strategic private equity firm focused exclusively on health care.

For more information on the company, visit:
http://www.aaipharma.com.

For more information about our analytical development services, visit:
http://aaipharma.com/development/analytical-development

For more information about our analytical testing services, visit:
http://aaipharma.com/analytical-testing/

 


'/>"/>
SOURCE AAIPharma Services Corp.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. AAIPharma Appoints Senior Director of Biopharmaceutical Development
2. AAIPharma Appoints Director Of Analytical Chemistry
3. Alere Inc. Announces Hiring of Namal Nawana as Chief Operating Officer
4. Northwest Biotherapeutics, Inc. Announces Full Exercise of Over- Allotment Option
5. Cadence Pharmaceuticals Announces Termination of Option Agreement to Acquire Incline Therapeutics, Inc.
6. River Vision Announces Completion of $17 million Series A Financing
7. Winner Medical Announces Closing of Going Private Transaction
8. Alere Inc. Announces Early Results of its Tender Offer and Consent Solicitation for Any and All of its 7.875% Senior Notes due 2016
9. IDEXX Laboratories Announces Entry Into Consent Agreement with FTC Bureau of Competition Staff
10. Valeant Completes Acquisition of Medicis and Announces Date of 2013 Financial Guidance Conference Call
11. Net Medical Xpress Announces Substantial Teleradiology Growth and Major New Opportunities in Diagnostic/Clinical Crossover Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016  Eli Lilly and ... results of its phase 3 EXPEDITION3 trial at the ... meeting. As previously disclosed, solanezumab did not meet the ... of solanezumab initiated in people with mild dementia due ... regulatory submissions for solanezumab for the treatment of mild ...
(Date:12/8/2016)... de dezembro de 2016  A Mederi Therapeutics Inc . anunciou aprovação ... não cirúrgico para a doença do refluxo gastroesofágico (DRGE). Foto -  ... ... Live Stretta procedure performed and broadcast during the Chinese ... Union Hospital , ...
(Date:12/8/2016)... Pa. , Dec. 8, 2016  Pennsylvania ... Secretary of Drug and Alcohol Programs Gary ... and insomnia medications, known as benzodiazepines, developed with ... "Benzodiazepines are medications that are frequently prescribed ... when they are used with opioid pain medications, ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... December 09, 2016 , ... Sober College, ... with the grand opening of the Sober College Robert Pfeifer Memorial Learning Center ... December 2-3, and was attended by an overwhelming amount of alumni, family, colleagues ...
(Date:12/9/2016)... , ... December 09, 2016 , ... "I had a ... inventor from Winchester, Va. "I thought that if the nebulizer had a more child-friendly ... than fearing them." , He developed the patent-pending NEBY to avoid the need to ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported local ... “This was our first franchise-wide Quack Gives Back initiative, and we’re ...
(Date:12/8/2016)... ... December 08, 2016 , ... With the increasing demand for dental implants, the ... (WIYM) campaign to inform dentists and patients about the safety issues related to dental ... market in the U.S. is projected to reach $6.4 billion in 2018 with more ...
(Date:12/8/2016)... ... 2016 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that it had joined the Pharmaceutical Supply Chain Initiative (PSCI). ... unite pharmaceutical and healthcare companies that share a vision of better, social, environmental ...
Breaking Medicine News(10 mins):